ArticleExperimental and therapeutic medicine2021

Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial.

Kidong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.